{"name": "ReNeuron Group",
 "permalink": "reneuron-group",
 "crunchbase_url": "http://www.crunchbase.com/company/reneuron-group",
 "homepage_url": "http://www.reneuron.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@reneuron.com",
 "phone_number": "+44 (0)1483 302560",
 "description": "",
 "created_at": "Tue Feb 23 04:14:04 UTC 2010",
 "updated_at": "Tue Feb 23 04:14:03 UTC 2010",
 "overview": "\u003Cp\u003EReNeuron Group Plc engages in the research, development, and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. It develops stem cell therapies for a range of neurodegenerative diseases and other conditions, including Parkinson\u00e2\u20ac\u2122s disease, Type 1 diabetes, and diseases of the retina. The company\u00e2\u20ac\u2122s therapeutic product pipeline includes ReN001, a pre-clinical development stage therapy for disabled stroke patients. Its other therapeutic and non-therapeutic programs in pre-clinical trials comprise ReN002 for diabetes, ReN003 for retinal diseases, ReN004 for Parkinson\u00e2\u20ac\u2122s disease, and ReN005 for Huntington\u00e2\u20ac\u2122s disease. ReNeuron Group also develops and markets neural stem cell lines that include ReNcell VM and ReNcell CX. The company was founded in 1997 and is headquartered in Guildford, the United Kingdom.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       26],
      "assets/images/resized/0007/7870/77870v1-max-150x150.png"],
     [[250,
       44],
      "assets/images/resized/0007/7870/77870v1-max-250x250.png"],
     [[301,
       54],
      "assets/images/resized/0007/7870/77870v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Michael",
      "last_name": "Hunt",
      "permalink": "michael-hunt",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "John",
      "last_name": "Sinden",
      "permalink": "john-sinden",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$7.3M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.fiercebiotech.com/story/reneuron-raises-7-3m/2010-02-22?utm_medium=rss\u0026utm_source=rss",
    "source_description": "ReNeuron raises $7.3M",
    "raised_amount": 7300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 2,
    "funded_day": 22,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "10 Nugent Road",
    "address2": "Surrey Research Park ",
    "zip_code": "GU2 7AF",
    "city": "Guildford",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}